Cibinqo
by Pfizer
Cibinqo (abrocitinib) is used to treat adults with moderate-to-severe atopic dermatitis, who have not responded to prior therapy, are not effectively managed by prescription therapies including biolog...
Cibinqo (abrocitinib) is used to treat adults with moderate-to-severe atopic dermatitis, who have not responded to prior therapy, are not effectively managed by prescription therapies including biologic drugs, or who are unable to tolerate other therapies. Cibinqo is a Janus Kinase (JAK) inhibitor that is available only via prescription. The suggested dosages for Cibinqo are 100mg and 200mg tablets; patients who are not responding to the 100 mg dose are advised to take the 200 mg dose.
Patient assistance programs
Cibinqo Patient Assistance Program
Manufacturer PAP- Eligibility
- Patients who meet income and insurance requirements
- Income limit
- Varies — contact ClariMeds for current limits
- Insurance
- Typically uninsured or underinsured; Medicare/Medicaid restrictions may apply
- How to apply
- Apply through ClariMeds — we handle the paperwork at no cost
Need help applying?
ClariMeds handles the entire application process for you — for free. See if you qualify in minutes.
See If You Qualify — Free